Literature DB >> 19914380

Interactions of gut microbiota with functional food components and nutraceuticals.

J M Laparra1, Y Sanz.   

Abstract

The human gut is populated by an array of bacterial species, which develop important metabolic and immune functions, with a marked effect on the nutritional and health status of the host. Dietary component also play beneficial roles beyond basic nutrition, leading to the development of the functional food concept and nutraceuticals. Prebiotics, polyunsaturated fatty acids (PUFAs) and phytochemicals are the most well characterized dietary bioactive compounds. The beneficial effects of prebiotics mainly relay on their influence on the gut microbiota composition and their ability to generate fermentation products (short-chain fatty acids) with diverse biological roles. PUFAs include the omega-3 and omega-6 fatty acids, whose balance may influence diverse aspects of immunity and metabolism. Moreover, interactions between PUFAs and components of the gut microbiota may also influence their biological roles. Phytochemicals are bioactive non-nutrient plant compounds, which have raised interest because of their potential effects as antioxidants, antiestrogenics, anti-inflammatory, immunomodulatory, and anticarcinogenics. However, the bioavailability and effects of polyphenols greatly depend on their transformation by components of the gut microbiota. Phytochemicals and their metabolic products may also inhibit pathogenic bacteria while stimulate the growth of beneficial bacteria, exerting prebiotic-like effects. Therefore, the intestinal microbiota is both a target for nutritional intervention and a factor influencing the biological activity of other food compounds acquired orally. This review focuses on the reciprocal interactions between the gut microbiota and functional food components, and the consequences of these interactions on human health. 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19914380     DOI: 10.1016/j.phrs.2009.11.001

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  126 in total

Review 1.  Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?

Authors:  Hollie I Swanson
Journal:  Drug Metab Dispos       Date:  2015-08-10       Impact factor: 3.922

2.  Consumption of dietary n-3 fatty acids decreases fat deposition and adipocyte size, but increases oxidative susceptibility in broiler chickens.

Authors:  Gemma González-Ortiz; Roser Sala; Elisa Cánovas; Nourhène Abed; Ana C Barroeta
Journal:  Lipids       Date:  2013-03-26       Impact factor: 1.880

Review 3.  Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Authors:  Abigail R Basson; Minh Lam; Fabio Cominelli
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

Review 4.  Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics.

Authors:  Rachel N Carmody; Peter J Turnbaugh
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

Review 5.  Gut Microbiome in Chronic Kidney Disease.

Authors:  R G Armani; A Ramezani; A Yasir; S Sharama; M E F Canziani; D S Raj
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

Review 6.  The gut microbiome and the brain.

Authors:  Leo Galland
Journal:  J Med Food       Date:  2014-12       Impact factor: 2.786

7.  Probiotic and Synbiotic Sorbets Produced with Jussara (Euterpe edulis) Pulp: Evaluation Throughout the Storage Period and Effect of the Matrix on Probiotics Exposed to Simulated Gastrointestinal Fluids.

Authors:  Júlia Fernanda Urbano Marinho; Marluci Palazzolli da Silva; Marcella Chalella Mazzocato; Fabrício Luiz Tulini; Carmen Sílvia Favaro-Trindade
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

Review 8.  Gut microbiota and attention deficit hyperactivity disorder: new perspectives for a challenging condition.

Authors:  María Carmen Cenit; Isabel Campillo Nuevo; Pilar Codoñer-Franch; Timothy G Dinan; Yolanda Sanz
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-03-13       Impact factor: 4.785

Review 9.  Developing a metagenomic view of xenobiotic metabolism.

Authors:  Henry J Haiser; Peter J Turnbaugh
Journal:  Pharmacol Res       Date:  2012-08-09       Impact factor: 7.658

10.  Fermentation of xylo-oligosaccharides obtained from wheat bran and Bengal gram husk by lactic acid bacteria and bifidobacteria.

Authors:  M S Madhukumar; G Muralikrishna
Journal:  J Food Sci Technol       Date:  2011-01-26       Impact factor: 2.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.